NCT02972645View on ClinicalTrials.gov

A Study of LY3305677 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 5, 2016

Primary Completion Date

July 14, 2017

Study Completion Date

July 14, 2017

Conditions
Healthy
Interventions
DRUG

LY3305677

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

LS2-9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02972645 - A Study of LY3305677 in Healthy Participants | Biotech Hunter | Biotech Hunter